CAR therapies
Researchers Test Single-Cell Whole-Genome Sequencing to Select Therapy in Relapsed Multiple Myeloma
Premium
At ASH's annual meeting, a study showed the potential for this method to inform the next treatment after patients relapse on BCMA- or GPRC5D-targeted therapy.
Celldom Lands $938K Phase II SBIR Grant From NCI
The grant will fund development of an application of Celldom's instrument for chimeric antigen receptor T-cell potency testing.
Caring Cross developed a method of manufacturing CAR T-cell therapies for about one-tenth of the typical cost and partnered with Fiocruz to deploy it in Brazil.
Researchers Showcase New Scores, Biomarkers, Signatures for Predicting CAR T-Cell Outcomes at ASH
Premium
Across three studies, researchers demonstrated how various biomarkers can inform trial design and predict lymphoma patients' outcomes on CAR T-cell therapy.
UMiami Researchers to Study Cell Therapy Response in Lymphoma Using WGS, Single-Cell RNA-seq
Premium
The team has received a $1.5 million US Department of Defense grant to help launch its project on diffuse B-cell lymphoma resistance to CAR T-cell therapy.